Skip to main content
TipRanks
Go Ultimate75% OFF
Until Labs logo

Until Labs: Valuation, Funding & Investors

Until Labs is a biotechnology company focused on developing advanced cryopreservation technologies to pause biological time. The company specializes in creating perfusion hardware, cryoprotective agents, and rewarming infrastructure to enable the reversible cryopreservation of biological systems, particularly donor organs. By preserving organs at low temperatures for indefinite storage and rewarming them for transplant, Until Labs aims to improve organ matching and reduce organ wastage, ultimately enhancing the outcomes for transplant patients.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$58M
Total Funding Rounds
1
Latest Funding Amount
$58M
Latest Funding Round
Series A

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 22, 2025Series A$58.00M―

Investors

Investor NameFunding Round
Lux CapitalSeries A
Founders FundSeries A
Field VenturesSeries A

Similar Companies

A snapshot of private companies similar to Until Labs, helping you discover and navigate related company profiles.

Related News and Analysis